GO:0042162 telomeric repeat DNA binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042162 (telomeric repeat DNA binding) describes the selective, non-covalent interaction of a protein with telomeric DNA repeat sequences.
• Telomeric repeat DNA binding is essential for chromosome end protection, telomere length regulation, and the prevention of inappropriate DNA damage responses.
• Key proteins include shelterin components such as TRF1, TRF2, POT1, RAP1, and TPP1, as well as telomerase and its accessory factors.
• Dysregulation of telomeric repeat DNA binding is implicated in cancer, replicative crisis, and premature aging syndromes.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models enable causal dissection of telomeric repeat DNA binding proteins.
• Advanced methods such as single-molecule analysis, ChIP, and proteomics are used to study telomeric repeat DNA binding in vitro and in vivo.
Description
Telomeric repeat DNA binding (GO:0042162) is a molecular function defined as any molecular function by which a gene product interacts selectively and non-covalently with a telomeric DNA repeat sequence. Telomeres are specialized nucleoprotein structures at the ends of linear chromosomes, composed of tandem DNA repeats and associated proteins. The binding of proteins to these repeats is fundamental to chromosome end protection, telomere length homeostasis, and the regulation of cellular lifespan. This function is distinct from general DNA binding because it requires sequence-specific recognition of the telomeric repeat, typically TTAGGG in vertebrates. Researchers study telomeric repeat DNA binding to understand how cells distinguish natural chromosome ends from DNA double-strand breaks. Proteins that bind telomeric repeats, such as TRF1, TRF2, and POT1, are critical for preventing end-to-end fusions and inappropriate activation of DNA damage checkpoints. Moreover, telomeric repeat DNA binding is central to the regulation of telomerase, the enzyme that extends telomeres, and to the alternative lengthening of telomeres (ALT) pathway in cancer cells. The importance of this function extends to aging, cancer, and stem cell biology. Defects in telomeric repeat DNA binding can lead to replicative crisis, genomic instability, and diseases such as dyskeratosis congenita and certain cancers. Understanding the molecular details of how proteins recognize telomeric repeats is therefore a major goal in biomedical research, with implications for therapeutic targeting of telomere maintenance in cancer and regenerative medicine.
telomeric repeat DNA binding At A Glance
| GO ID | GO:0042162 |
|---|---|
| GO term | telomeric repeat DNA binding |
| Ontology | molecular_function |
| Synonym | telomere binding, telomeric repeat binding |
| Major function | Selective, non-covalent interaction with telomeric DNA repeat sequences |
| Definition source | QuickGO |
| Related processes | Telomere maintenance, chromosome end protection, telomerase regulation |
| Key proteins | TRF1, TRF2, POT1, RAP1, TPP1, telomerase |
What Is GO:0042162?
GO:0042162, telomeric repeat DNA binding, is a molecular function term describing the selective and non-covalent interaction of a gene product with a telomeric DNA repeat sequence. This binding is sequence-specific and is essential for the assembly of protective nucleoprotein complexes at chromosome ends. It encompasses the initial recognition of telomeric repeats by proteins such as TRF1, TRF2, and POT1, and does not include covalent modification or general DNA binding.
Why Is telomeric repeat DNA binding Important in Cell Biology?
Telomeric repeat DNA binding is fundamental to genome stability because it allows cells to distinguish natural chromosome ends from DNA breaks. Proteins that bind telomeric repeats form the shelterin complex, which protects chromosome ends from being recognized as damage and regulates telomere length. This function is also critical for the regulation of telomerase and the ALT pathway, both of which are activated in most cancers to maintain telomeres and support unlimited proliferation. Consequently, understanding telomeric repeat DNA binding has direct implications for cancer therapy, aging research, and the development of drugs that target telomere maintenance.
• Protects chromosome ends from being recognized as DNA double-strand breaks.
• Regulates telomere length homeostasis by controlling telomerase access.
• Prevents end-to-end chromosome fusions and genomic instability.
• Mediates replicative crisis and senescence signaling.
• Is exploited by cancer cells to maintain telomeres via ALT or telomerase reactivation.
• Mutations in telomere-binding proteins cause dyskeratosis congenita and other telomeropathies.
• Serves as a target for anti-cancer therapies that aim to disrupt telomere maintenance.
• Provides a model system for studying sequence-specific DNA recognition.
• Enables single-molecule analysis of protein-DNA interactions.
• Links telomere biology to mitochondrial signaling and innate immune pathways.
Molecular Mechanism of telomeric repeat DNA binding
Recognition of Telomeric Repeats
In simple terms: Proteins find and stick to the repeated DNA sequences at chromosome ends.
Telomeric repeat DNA binding begins with the sequence-specific recognition of tandem TTAGGG repeats by specialized proteins. TRF1 and TRF2 contain Myb-type DNA-binding domains that insert into the DNA major groove and recognize the telomeric repeat sequence with high affinity. POT1, a member of the shelterin complex, binds the single-stranded G-overhang with high specificity, discriminating telomeric repeats from other sequences. This recognition is non-covalent and reversible, allowing dynamic regulation of telomere protection.
Assembly of the Shelterin Complex
In simple terms: Multiple proteins come together to form a protective cap on chromosome ends.
Once TRF1 and TRF2 bind double-stranded telomeric repeats, they recruit other shelterin components including RAP1, TIN2, TPP1, and POT1. RAP1 interacts with TRF2 and inhibits DNA-PK-mediated non-homologous end joining, thereby preventing inappropriate DNA repair at telomeres. The shelterin complex forms a higher-order structure that protects chromosome ends and regulates telomerase access. This assembly is essential for chromosome end protection and for the suppression of DNA damage signaling.
Regulation of Telomerase Access
In simple terms: Telomere-binding proteins control whether telomerase can add more repeats.
Telomeric repeat DNA binding proteins regulate telomerase by controlling its access to the chromosome end. Telomerase binds the RNA template and DNA telomeric repeat with flexibility, allowing processive addition of repeats. POT1 and TPP1 form a heterodimer that interacts with telomerase and modulates its activity. POT1 preferentially binds the terminal DNA repeat on the G-overhang, and this binding is critical for regulating telomere elongation. The interplay between shelterin and telomerase ensures telomere length homeostasis.
Single-Stranded G-Overhang Binding
In simple terms: Some proteins bind the single-stranded tail at the very end of the chromosome.
The telomeric G-overhang is a single-stranded extension of TTAGGG repeats that is bound by POT1 and other single-stranded telomeric DNA-binding proteins. POT-3, a homolog of POT1, preferentially binds the terminal DNA repeat on the telomeric G-overhang, suggesting a specialized role in end protection. This binding is essential for preventing the G-overhang from being recognized as damaged DNA and for regulating telomerase-mediated extension. Single-molecule studies have revealed the dynamic nature of these interactions.
Higher-Order Structures and Quadruplexes
In simple terms: Telomeric DNA can fold into special shapes that proteins recognize.
Telomeric repeats can form G-quadruplex structures, which are four-stranded DNA conformations. Proteins that bind telomeric repeats may also interact with these higher-order structures, influencing telomere stability and function. DNA and RNA quadruplex-binding proteins have been identified, and their interactions with telomeric repeats are an active area of research. The formation of G-quadruplexes can affect telomerase activity and telomere maintenance.
Signaling to Mitochondria and Innate Immunity
In simple terms: Telomere-binding proteins can send signals to other parts of the cell when telomeres become too short.
During replicative crisis, telomere shortening triggers a signaling cascade involving ZBP1 and mitochondrial dysfunction. Telomere-to-mitochondria signaling by ZBP1 mediates replicative crisis, linking telomeric repeat DNA binding to innate immune pathways. This pathway is activated when telomeres become critically short and contributes to cell death or senescence. The integration of telomere status with mitochondrial and immune signaling highlights the broader physiological importance of telomeric repeat DNA binding.
Key Genes Involved in GO:0042162 telomeric repeat DNA binding
The following genes encode proteins that directly or indirectly participate in telomeric repeat DNA binding and its regulation.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TERF1 (TRF1) | Binds double-stranded telomeric repeats; regulates telomere length | Key shelterin component; knockout causes telomere elongation and genomic instability |
| TERF2 (TRF2) | Binds double-stranded telomeric repeats; protects chromosome ends | Essential for end protection; knockout leads to end-to-end fusions and DNA damage response |
| POT1 | Binds single-stranded G-overhang; regulates telomerase | Mutations linked to cancer and telomere-related diseases |
| RAP1 (TERF2IP) | Interacts with TRF2; inhibits DNA-PK at telomeres | Knockout causes telomere dysfunction and DNA repair activation |
| TPP1 (ACD) | Partners with POT1; recruits telomerase | Mutations cause dyskeratosis congenita and related disorders |
| TINF2 | Shelterin component; bridges TRF1/TRF2 and POT1/TPP1 | Mutations cause severe dyskeratosis congenita |
| TERT | Catalytic subunit of telomerase; extends telomeric repeats | Overexpressed in most cancers; target for anti-cancer therapy |
| TERC | RNA template of telomerase | Mutations cause dyskeratosis congenita; essential for telomerase activity |
| ZBP1 | Senses telomere dysfunction; mediates replicative crisis | Links telomere shortening to mitochondrial signaling and innate immunity |
| POT-3 (C. elegans) | Binds terminal DNA repeat on G-overhang | Model for studying POT1 homolog function |
| DNA-PK | DNA repair kinase; inhibited by RAP1 at telomeres | Target for understanding end protection |
| BLM | RecQ helicase; resolves G-quadruplexes at telomeres | Mutations cause Bloom syndrome; involved in ALT |
| WRN | RecQ helicase; maintains telomere stability | Mutations cause Werner syndrome; interacts with telomeric DNA |
| RAD51 | Homologous recombination factor; involved in ALT | Key player in alternative lengthening of telomeres |
| SLX4 | Structure-specific endonuclease; resolves telomere recombination | Involved in ALT and telomere maintenance |
| FANCD2 | Fanconi anemia protein; telomere protection | Links telomere biology to DNA repair disorders |
| ATM | DNA damage kinase; activated by telomere dysfunction | Mediates replicative crisis signaling |
| ATR | DNA damage kinase; responds to telomere replication stress | Involved in telomere maintenance and crisis |
How Is telomeric repeat DNA binding Regulated?
Telomeric repeat DNA binding is regulated at multiple levels. Post-translational modifications of shelterin components, such as phosphorylation by ATM and ATR, modulate their binding affinity and interactions. Telomerase recruitment to telomeres is regulated by TPP1 and POT1, which control the access of telomerase to the G-overhang. Additionally, the formation of G-quadruplex structures can inhibit telomerase activity and is resolved by helicases such as BLM and WRN. RAP1-mediated inhibition of DNA-PK provides a regulatory mechanism to prevent inappropriate DNA repair at telomeres. During replicative crisis, ZBP1-mediated signaling to mitochondria is activated when telomeres become critically short, linking telomere status to innate immunity.
telomeric repeat DNA binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| POT1 | Familial melanoma, chronic lymphocytic leukemia | Knockout or point mutation in melanoma cell lines |
| TERT | Dyskeratosis congenita, aplastic anemia, cancer | Overexpression in cancer cell lines; knockout in stem cells |
| TERF2 (TRF2) | Cancer, telomere dysfunction | Conditional knockout in mouse models |
| RAP1 (TERF2IP) | Telomere dysfunction, cancer | Knockout in human cell lines |
| ZBP1 | Replicative crisis, autoinflammatory disease | Knockout in fibroblasts; overexpression in cancer cells |
Cancer and Telomere Maintenance
Cancer cells require a telomere maintenance mechanism to achieve unlimited proliferation. Most cancers reactivate telomerase, while 10-15% use the alternative lengthening of telomeres (ALT) pathway. Telomeric repeat DNA binding proteins are critical for both mechanisms. For example, centromeric footprints preserve telomere integrity in ALT cancers, and disruption of these interactions leads to telomere dysfunction and cell death. Mutations in POT1 and other shelterin genes are associated with familial melanoma, chronic lymphocytic leukemia, and other cancers. Targeting telomeric repeat DNA binding is therefore a promising anti-cancer strategy.
Replicative Crisis and Aging
When telomeres become critically short, cells enter replicative crisis, a state characterized by genomic instability and cell death. Telomere-to-mitochondria signaling by ZBP1 mediates this crisis, linking telomeric repeat DNA binding to mitochondrial dysfunction and innate immune activation. Defects in telomere protection can accelerate aging and lead to premature aging syndromes such as Werner syndrome and Bloom syndrome. Understanding how telomeric repeat DNA binding regulates crisis may provide insights into aging and age-related diseases.
Telomeropathies and Bone Marrow Failure
Mutations in genes encoding telomeric repeat DNA binding proteins or telomerase components cause a group of diseases known as telomeropathies, including dyskeratosis congenita, aplastic anemia, and pulmonary fibrosis. These diseases are characterized by premature telomere shortening and stem cell exhaustion. For example, mutations in TINF2, TERT, and TERC lead to severe bone marrow failure. RAP1-mediated inhibition of DNA-PK is also important for preventing telomere dysfunction, and its loss can contribute to disease pathology.
From telomeric repeat DNA binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of TRF2 cause telomere fusions? | CRISPR knockout of TERF2 in human fibroblasts |
| How does POT1 mutation affect telomere length? | Point mutation knock-in of POT1 in cancer cell lines |
| Can telomerase recruitment be enhanced? | Knock-in of TPP1 mutations that increase telomerase binding |
| Where does RAP1 localize at telomeres? | Tagged knock-in of RAP1 with GFP in U2OS cells |
| Does overexpression of TERT immortalize cells? | Overexpression of TERT in primary fibroblasts |
| What is the role of ZBP1 in crisis? | Knockout of ZBP1 in cells undergoing replicative crisis |
How to Study the telomeric repeat DNA binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Single-molecule analysis | Binding kinetics and forces | Studying protein-DNA interactions at telomeres |
| ChIP-seq | Genome-wide binding sites | Mapping shelterin components at telomeres |
| Proteomics | Protein interactions and modifications | Identifying novel telomere-binding proteins |
| Live-cell imaging | Real-time telomere dynamics | Visualizing telomere protection in living cells |
| Telomere length assay (TRF) | Telomere length | Assessing effects of mutations in telomere-binding proteins |
| G-quadruplex assays | Quadruplex formation and stability | Studying telomeric DNA structures |
| CRISPR screening | Gene function in telomere maintenance | Identifying regulators of telomeric repeat DNA binding |
| Bioinformatics | Sequence analysis and prediction | Analyzing telomeric repeat sequences and protein domains |
Single-Molecule Analysis of Telomeric DNA Binding
Single-molecule techniques such as optical tweezers and atomic force microscopy allow direct observation of protein-DNA interactions at telomeric repeats. Purification of mammalian telomeric DNA for single-molecule analysis enables precise measurement of binding kinetics and forces. These methods reveal dynamic binding and unfolding of telomeric DNA structures, providing insights into how proteins recognize and protect chromosome ends.
Chromatin Immunoprecipitation and Telomere ChIP
ChIP and its variants (ChIP-seq, ChIP-qPCR) are used to map the binding of proteins to telomeric repeats in vivo. By crosslinking proteins to DNA and immunoprecipitating with specific antibodies, researchers can determine the occupancy of TRF1, TRF2, POT1, and other factors at telomeres. This method is essential for understanding how telomeric repeat DNA binding is regulated across the cell cycle and in disease states.
Proteomics and Interactome Analysis
Mass spectrometry-based proteomics can identify proteins that bind telomeric repeats. By using biotinylated telomeric DNA probes and pull-down assays, researchers can isolate and identify novel telomere-binding proteins. This approach has revealed the composition of the shelterin complex and its associated factors. Proteomics also allows the study of post-translational modifications that regulate telomeric repeat DNA binding.
Live-Cell Imaging of Telomeres
Fluorescence microscopy with fluorescently tagged telomere-binding proteins (e.g., GFP-TRF1, GFP-POT1) enables real-time visualization of telomere dynamics in living cells. This method can reveal how telomeric repeat DNA binding changes during the cell cycle, in response to DNA damage, and during crisis. Live-cell imaging combined with single-molecule tracking provides quantitative measurements of binding kinetics.
How CRISPR Can Be Used to Study GO:0042162 telomeric repeat DNA binding
Knockout
CRISPR knockout of genes encoding telomeric repeat DNA binding proteins, such as TERF1, TERF2, POT1, and RAP1, allows researchers to study their loss-of-function phenotypes. For example, knockout of TERF2 leads to telomere fusions and DNA damage response activation. Knockout of ZBP1 impairs replicative crisis signaling. These models are essential for dissecting the causal roles of telomere-binding proteins in genome stability and disease.
Point Mutation
Point mutations can be introduced into genes encoding telomere-binding proteins to mimic disease-associated variants or to disrupt specific functions. For instance, point mutations in POT1 found in familial melanoma can be knocked into cell lines to study their effects on telomere length and protection. Point mutations in TERT can reveal residues critical for telomerase activity and processivity.
Knock-in
Knock-in of tagged versions of telomere-binding proteins (e.g., GFP-TRF1, HA-POT1) enables visualization and biochemical analysis of these proteins at endogenous levels. Knock-in of disease-associated mutations or of reporter genes under the control of telomere-binding protein promoters provides valuable tools for studying telomere biology. Knock-in of TPP1 mutations can be used to study telomerase recruitment.
Overexpression
Overexpression of telomeric repeat DNA binding proteins, such as TERT or TRF2, can be achieved by CRISPR-mediated knock-in of strong promoters or by lentiviral transduction. Overexpression of TERT immortalizes primary cells and is a common model for studying telomere maintenance in cancer. Overexpression of POT1 or its mutants can reveal dominant-negative effects on telomere protection.
How EDITGENE Supports telomeric repeat DNA binding Research
Researchers studying telomeric repeat DNA binding-related genes often need to determine whether a candidate gene is causally involved in telomere maintenance, chromosome end protection, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for telomeric repeat DNA binding research.
Frequently Asked Questions About telomeric repeat DNA binding
What is telomeric repeat DNA binding?
Telomeric repeat DNA binding (GO:0042162) is the selective, non-covalent interaction of a protein with telomeric DNA repeat sequences, such as TTAGGG in vertebrates.
What genes are involved in telomeric repeat DNA binding?
Key genes include TERF1 (TRF1), TERF2 (TRF2), POT1, RAP1 (TERF2IP), TPP1 (ACD), TINF2, TERT, and TERC.
How does telomeric repeat DNA binding protect chromosome ends?
Proteins like TRF2 and RAP1 form the shelterin complex, which prevents chromosome ends from being recognized as DNA breaks and inhibits inappropriate DNA repair.
What diseases are associated with defects in telomeric repeat DNA binding?
Defects are linked to dyskeratosis congenita, aplastic anemia, pulmonary fibrosis, familial melanoma, and other cancers.
How can I study telomeric repeat DNA binding in the lab?
Common methods include ChIP, single-molecule analysis, proteomics, live-cell imaging, and CRISPR-based gene editing.
What is the role of POT1 in telomeric repeat DNA binding?
POT1 binds the single-stranded G-overhang with high specificity and regulates telomerase access to telomeres.
How does telomerase interact with telomeric repeats?
Telomerase binds the RNA template and DNA telomeric repeat with flexibility, allowing processive addition of repeats.
What is the alternative lengthening of telomeres (ALT) pathway?
ALT is a telomerase-independent mechanism of telomere maintenance used by some cancers, involving homologous recombination and telomeric repeat DNA binding proteins.
Can CRISPR be used to study telomeric repeat DNA binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect the functions of telomere-binding proteins.
What is replicative crisis and how is it related to telomeric repeat DNA binding?
Replicative crisis is a state of genomic instability triggered by critically short telomeres; ZBP1-mediated signaling links telomere dysfunction to mitochondria and innate immunity.
Conclusion
Telomeric repeat DNA binding (GO:0042162) is a fundamental molecular function that safeguards chromosome ends and regulates cellular lifespan. Proteins such as TRF1, TRF2, POT1, and RAP1 recognize telomeric repeats to form protective complexes that prevent DNA damage responses and control telomerase activity. Dysregulation of this function contributes to cancer, aging, and telomeropathies, making it a prime target for therapeutic intervention. Advances in CRISPR-based gene editing and single-molecule analysis continue to illuminate the mechanistic details of telomeric repeat DNA binding. EDITGENE's comprehensive services, including knockout, point mutation, knock-in, overexpression, and library screening, empower researchers to explore this critical function and translate findings into clinical applications.
References
- 1. Nassour J et al.. 2023. Telomere-to-mitochondria signalling by ZBP1 mediates replicative crisis.. Nature 614(7949):767-773 PMID: 36755096
- 2. Choi WS et al.. 2022. Flexibility of telomerase in binding the RNA template and DNA telomeric repeat.. Proc Natl Acad Sci U S A 119(1) PMID: 34969861
- 3. Yu X et al.. 2023. POT-3 preferentially binds the terminal DNA-repeat on the telomeric G-overhang.. Nucleic Acids Res 51(2):610-618 PMID: 36583365
- 4. Lin JJ. 1993. Telomeric DNA binding proteins.. Bioessays 15(8):555-7 PMID: 8135769
- 5. Bhargava R et al.. 2026. Centromeric footprints preserve telomere integrity in ALT cancers.. Nature 656(8127):406-414 PMID: 42236945
- 6. Brázda V et al.. 2014. DNA and RNA quadruplex-binding proteins.. Int J Mol Sci 15(10):17493-517 PMID: 25268620
- 7. Mazzucco G et al.. 2022. Purification of mammalian telomeric DNA for single-molecule analysis.. Nat Protoc 17(6):1444-1467 PMID: 35396546
- 8. Eickhoff P et al.. 2025. Chromosome end protection by RAP1-mediated inhibition of DNA-PK.. Nature 642(8069):1090-1096 PMID: 40240611
